McKesson Corporation (MCK) - Total Assets
Based on the latest financial reports, McKesson Corporation (MCK) holds total assets worth $84.19 Billion USD as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See McKesson Corporation shareholders equity for net asset value and shareholders' equity analysis.
McKesson Corporation - Total Assets Trend (1995–2025)
This chart illustrates how McKesson Corporation's total assets have evolved over time, based on quarterly financial data.
McKesson Corporation - Asset Composition Analysis
Current Asset Composition (March 2025)
McKesson Corporation's total assets of $84.19 Billion consist of 73.7% current assets and 26.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $5.69 Billion | 7.6% |
| Accounts Receivable | $25.64 Billion | 34.1% |
| Inventory | $23.00 Billion | 30.6% |
| Property, Plant & Equipment | $4.28 Billion | 5.7% |
| Intangible Assets | $1.46 Billion | 2.0% |
| Goodwill | $10.02 Billion | 13.3% |
Asset Composition Trend (1995–2025)
This chart illustrates how McKesson Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of McKesson Corporation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: McKesson Corporation's current assets represent 73.7% of total assets in 2025, a decrease from 77.6% in 1995.
- Cash Position: Cash and equivalents constituted 7.6% of total assets in 2025, down from 11.1% in 1995.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 6.0% in 1995.
- Asset Diversification: The largest asset category is accounts receivable at 34.1% of total assets.
McKesson Corporation Competitors by Total Assets
Key competitors of McKesson Corporation based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG
|
Australia | AU$8.74 Billion |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3
|
Brazil | R$5.64 Billion |
|
Ebos Group Ltd
AU:EBO
|
Australia | AU$7.84 Billion |
|
Paragon Care Ltd
AU:PGC
|
Australia | AU$1.31 Billion |
|
Mayne Pharma Group Ltd
AU:MYX
|
Australia | AU$1.01 Billion |
|
Cyclopharm Ltd
AU:CYC
|
Australia | AU$55.91 Million |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607
|
China | CN¥233.15 Billion |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332
|
China | CN¥83.17 Billion |
McKesson Corporation - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.88 | 0.88 | 1.03 |
| Quick Ratio | 0.48 | 0.48 | 0.59 |
| Cash Ratio | 0.04 | 0.02 | 0.00 |
| Working Capital | $-8.43 Billion | $-6.82 Billion | $1.28 Billion |
McKesson Corporation - Advanced Valuation Insights
This section examines the relationship between McKesson Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 5.04 |
| Latest Market Cap to Assets Ratio | 1.32 |
| Asset Growth Rate (YoY) | 11.4% |
| Total Assets | $75.14 Billion |
| Market Capitalization | $98.95 Billion USD |
Valuation Analysis
Above Book Valuation: The market values McKesson Corporation's assets above their book value (1.32x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: McKesson Corporation's assets grew by 11.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for McKesson Corporation (1995–2025)
The table below shows the annual total assets of McKesson Corporation from 1995 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | $75.14 Billion | +11.41% |
| 2024-03-31 | $67.44 Billion | +8.22% |
| 2023-03-31 | $62.32 Billion | -1.55% |
| 2022-03-31 | $63.30 Billion | -2.64% |
| 2021-03-31 | $65.02 Billion | +6.15% |
| 2020-03-31 | $61.25 Billion | +2.64% |
| 2019-03-31 | $59.67 Billion | -1.17% |
| 2018-03-31 | $60.38 Billion | -0.96% |
| 2017-03-31 | $60.97 Billion | +7.79% |
| 2016-03-31 | $56.56 Billion | +5.00% |
| 2015-03-31 | $53.87 Billion | +4.08% |
| 2014-03-31 | $51.76 Billion | +48.79% |
| 2013-03-31 | $34.79 Billion | +5.12% |
| 2012-03-31 | $33.09 Billion | +7.15% |
| 2011-03-31 | $30.89 Billion | +9.57% |
| 2010-03-31 | $28.19 Billion | +11.56% |
| 2009-03-31 | $25.27 Billion | +2.70% |
| 2008-03-31 | $24.60 Billion | +2.76% |
| 2007-03-31 | $23.94 Billion | +14.15% |
| 2006-03-31 | $20.98 Billion | +11.72% |
| 2005-03-31 | $18.77 Billion | +15.61% |
| 2004-03-31 | $16.24 Billion | +13.15% |
| 2003-03-31 | $14.35 Billion | +7.73% |
| 2002-03-31 | $13.32 Billion | +15.56% |
| 2001-03-31 | $11.53 Billion | +11.15% |
| 2000-03-31 | $10.37 Billion | +14.22% |
| 1999-03-31 | $9.08 Billion | +61.95% |
| 1998-03-31 | $5.61 Billion | +8.40% |
| 1997-03-31 | $5.17 Billion | +47.63% |
| 1996-03-31 | $3.50 Billion | +0.71% |
| 1995-03-31 | $3.48 Billion | -- |
About McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related produc… Read more